tirzepatide pregnancy human data TLDR on GLP-1 receptor agonists (ozempic, wegovy, monjauro, zepbound etc etc) animal studies suggest a possible association with birth defects, low fetal weight, and miscarriage but (which is limited to How can a woman of

This makes it a strong option for those struggling to keep their diabetes under control

10.1016/j.ijbiomac.2024.132256 47 YabeD.KawamoriD.SeinoY.OuraT.TakeuchiM

do not use it if you or a family member has had medullary thyroid carcinoma or MEN 2

Muhammed will help you decide which medication is the better choice for your weight loss and health goals

By addressing multiple factors that contribute to cardiovascular disease, this innovative medication has the potential to reduce the risk of heart-related complications in individuals with diabetes

In late 2023, the Food and Drug Administration (FDA) approved tirzepatide under the brand name Zepbound for chronic weight management in adults with obesity [Body Mass Index (BMI) 30] or overweight (BMI 27 with at least one weight-related condition)